Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Raquel Rocha is active.

Publication


Featured researches published by Raquel Rocha.


British Journal of Nutrition | 2009

Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase.

Raquel Rocha; Genoile Oliveira Santana; Neogélia Almeida; André Castro Lyra

Inflammatory bowel disease (IBD) is often associated with malnutrition. The aim of this study was to compare the body composition of outpatients with IBD during remission and active phase. In order to evaluate disease activity we used Crohns Disease Activity Index for Crohns disease (CD) patients and Lichtigers Index for ulcerative colitis (UC) patients. All patients underwent the analysis of BMI, arm muscle area (AMA) and triceps plus subscapula skinfold thickness (TST+SST) to identify total, muscle and fat mass, respectively. In total 102 patients were evaluated (CD, n 50; UC, n 52) and the majority was young women. Malnutrition according to BMI was found in 14.0 % of patients with CD and 5.7 % of UC patients. Muscle mass depletion was detected in more than half of the CD and UC patients. The BMI, TST+SST and AMA values were lower in the active phase only in CD patients (P < 0.05). Fat mass depletion was associated with active phase in both CD and UC patients. Body composition parameters obtained using BMI, TST+SST and AMA were not correlated with the presence of fistula in CD patients (P>0.05). In conclusion, patients without signs of malnutrition had fat mass depletion especially in the active phase and muscle mass depletion occurred both in CD and UC patients.


European Journal of Gastroenterology & Hepatology | 2005

Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum.

Ana Cristina Siqueira; Helma Pinchemel Cotrim; Raquel Rocha; Fernando Martins Carvalho; Luiz Antonio Rodrigues de Freitas; Danyella Barreto; Leandro Gouveia; Luciana Landeiro

Background Non-alcoholic fatty liver disease (NAFLD) has been associated with several metabolic conditions (MC) and secondary causes, but the relationship between insulin resistance (IR) and the underlying aetiology of NAFLD has not been extensively explored. Objective To determine the frequency of IR among NAFLD patients and to describe IR according to risk factors and histological findings of the disease. Methodology A case-series study of 64 patients with clinical and histological diagnosis of NAFLD. IR was calculated by homeostasis model assessment (HOMA) and IR was considered when HOMA ⩾3. Histological grades of NAFLD were: stage 1, steatosis isolated; stage 2, steatosis and inflammation; stage 3, steatosis and ballooning degeneration; stage 4, steatosis and fibrosis and/or Mallory bodies. Fibrosis was graded 0–4 (cirrhosis). Results IR was found in 21 (33%) patients. Among those with IR, 16 patients (76%) had associated MC and five patients (24%) had exposure to petrochemicals. The mean value of HOMA varied from 3.5 in NAFLD associated with MC to 1.6 in patients with exposure to petrochemicals (P<0.03). Waist circumference was the metabolic factor most strongly associated with IR (P<0.005). Steatohepatitis (NASH) was observed in 54 (84.3%) cases. The HOMA mean value was significantly higher in patients with advanced fibrosis. Conclusions IR occurred in 33% of the NAFLD patients, being more frequent among those with MC than among those with exposure to petrochemicals. The presence of IR in cases with advanced fibrosis suggests that it may influence the prognosis of NAFLD.


Arquivos De Gastroenterologia | 2007

Fibras solúveis no tratamento da doença hepática gordurosa não-alcoólica: estudo piloto

Raquel Rocha; Helma Pinchemel Cotrim; Ana Cristina Siqueira; Shirley Floriano

The pilot study evaluated the efficiency of oral soluble fibers to treat patients with nonalcoholic fatty liver disease. Twelve patients received 10 g/day of soluble fibers during 3 months. After the treatment 100% of patients presented reduction in body mass index, waist circumference and insulin resistance index. In 66.7% of the patients were observed reduction of the cholesterol levels and 75% presented normal liver enzymes (AST, ALT, and GGT). The present study suggests that oral soluble fibers may be useful to control risk factors and liver enzymes in patients with nonalcoholic fatty liver disease. However, future studies with histological controls are considered necessary.


Brain Injury | 2012

Tolerance to enteral nutrition therapy in traumatic brain injury patients.

Tatiana Fuchs Pinto; Raquel Rocha; Cristiane Assis Paula; Rosângela Passos de Jesús

Objective: To evaluate the tolerance to enteral nutrition (EN) and the effects of pro-kinetic drugs in critical traumatic brain injury (TBI) patients. Methods: Transversal observational study. A total of 32 out of 45 TBI patients of both genders receiving EN were evaluated in a trauma referral hospital intensive care unit (ICU). Data from each patient were collected for a period of 10 consecutive days after initiation of enteral feeding: gastric residue, presence of vomiting, abdominal distension, Glasgow coma scale and the use of pro-kinetic agents. Results: In 20 of the 32 patients high levels of gastric residue were found. Of these 20 patients, half could not tolerate the diet within the first 72 hours following infusion. However, no association was found between disease severity and occurrence of gastrointestinal complications (p > 0.05). Feeding intolerance was observed in 75.0% (n = 24) of patients, even with the systematic use of metaclopramide from the outset of nutritional therapy. All patients with feeding intolerance who used erythromycin by nasogastric tube showed improvement. Conclusions: The high level of gastric residue was the most common feeding intolerance and the delivery of erythromycin by nasogastric tube seems to control gastrointestinal disorders in TBI patients.


Journal of Crohns & Colitis | 2012

Does obesity complicate inflammatory bowel diseases

Ana Tieko Meyer Nascimento; Raquel Rocha; Genoile Oliveira Santana; Fernanda Gomes Coqueiro; André Castro Lyra

Dear Sir, Although it seems an unlikely co-morbidity due to the prevalence of malnutrition in inflammatory bowel diseases (IBD) patients, obesity has been observed in these patients, even in children.1 The obesity seems to be associated with increased disease severity, anorectal complications and hospitalizations in Crohns disease (CD) patients.2 There are report benefits in clinical course and inflammatory markers after reduction of weight in obese ulcerative colitis (UC) patients.3 However, there are reports of two obese patients, one who developed UC after Masons vertical banded gastroplasty, and in another case UC was …


World Journal of Hepatology | 2018

Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: A review

Naiade Silveira Almeida; Raquel Rocha; Helma Pinchemel Cotrim; Carla Daltro

The objective was to critically analyze studies that evaluated the predictive capacity of indicators of visceral adiposity in non-alcoholic fatty liver disease (NAFLD). The bibliographic research was carried out using the electronic database PubMed, LILACS and SciELO, references of selected articles. Although we found few studies, they have already used several indicators of visceral adiposity as waist circumference, waist-to-hip ratio, waist-to-height ratio, Lipid accumulation product, Body Shape Index, Body Roundness Index and most them were good predictors of NAFLD. Thus, the anthropometric indicators may contribute for the diagnosis of NAFLD in a simple, low-cost and non-invasive way, allowing early therapeutic measures to prevent the evolution to non-alcoholic steatohepatitis.


Intestinal Research | 2018

What nutritional factors influence bone mineral density in Crohn's disease patients?

Fernanda Gomes Coqueiro; Raquel Rocha; Camilla Menezes; Mirella Brasil Lopes; Vanessa Rosa Oliveira; Flora Fortes; Genoile Oliveira Santana

Background/Aims Bone mineral density (BMD) is often low in patients with Crohns disease (CD). This study aimed to evaluate the association between nutritional factors and BMD in a group of CD patients. Methods CD patients 18 years of age or older were included. The body mass index (BMI), waist circumference (WC) and dietary intake were evaluated during two 24-hour recalls. Bone densitometry was performed by dual-energy X-ray absorptiometry of the full body to assess body composition and of the lumbar vertebrae and femoral neck to assess BMD. Results In the 60 patients evaluated, there was no association between BMD and disease activity or between BMD and disease duration. We observed moderate correlations between BMD in at least one of the evaluated sites and BMI, lean mass, WC, and protein, calcium, phosphorus and magnesium dietary intakes (P<0.05). In the linear regression analysis for spinal BMD, only BMI and calcium dietary intake remained associated (P<0.05). In the linear regression analysis for femoral BMD, WC and phosphorus intake continued to be significant in the final model, although they had low explanatory power for BMD (P<0.05). Conclusions The prevalence of low BMD was high in CD patients. BMI, WC, calcium and phosphorus dietary intake were positively correlated with BMD.


Diabetology & Metabolic Syndrome | 2015

Dietary glycemic assessment and type of lens opacity in patients with age-related cataract

Clarissa Simon Factum; Nívea Almeida Casé; Raquel Rocha; Juliete Santos Cortez; Emily David Brandão; Igor Barbosa Mendes; Eduardo Ferrari Marback

Materials and methods This was an exploratory cross-sectional study, carried out at the Outpatient Clinics of Nutrition and Ophthalmology at the Federal University of Bahia, Salvador-Bahia, Brazil. Seventy eight patients, of both genders, with age-related cataract, participated. All patients underwent nutritional, clinical and ophthalmological assessment. Type of lens opacity was determined following Lens Opacity Classification System – LOCS III – criteria. Clinical data regarding fasting glucose, diabetes diagnosis and hypertension were collected from medical records. Participants answered two


Journal of Human Nutrition and Dietetics | 2005

Body mass index and waist circumference in non-alcoholic fatty liver disease

Raquel Rocha; Helma Pinchemel Cotrim; Fernando Martins Carvalho; Ana Cristina Siqueira; Hélio Braga; Luis Freitas


Annals of Hepatology | 2009

Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery.

Antônio Ricardo Cardia Ferraz de Andrade; Helma Pinchemel Cotrim; Erivaldo Alves; Daniela Soares; Raquel Rocha; Alessandro de Moura Almeida; Carolina de Godoy Almeida; Luiz Antônio de Freitas

Collaboration


Dive into the Raquel Rocha's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

André Castro Lyra

Federal University of Bahia

View shared research outputs
Top Co-Authors

Avatar

Neogélia Almeida

Federal University of Bahia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge